Brinzolamide
Back to searchMolecule Structure
Scientific Name
Brinzolamide
Description of the Drug
Brinzolamide is a carbonic anhydrase inhibitor used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01194
http://www.drugbank.ca/drugs/DB01194
Brand Name(s)
Azopt
Company Owner(s)
Bausch And Lomb Inc, Watson Laboratories Inc, Alcon Laboratories Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase II | SINGLE PROTEIN | INHIBITOR | CHEMBL205 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24636 | |
| PharmGKB | PA164744929 | |
| Human Metabolome Database | HMDB0015325 | |
| DrugBank | DB01194 | |
| PubChem: Thomson Pharma | 14780300 | 14878101 |
| PubChem | 68844 | |
| LINCS | LSM-3677 | |
| Nikkaji | J1.143.859H | |
| PDBe | BZ1 | |
| BindingDB | 10885 | |
| EPA CompTox Dashboard | DTXSID6045531 | |
| DrugCentral | 396 | |
| Brenda | 1606 | 226380 |
| ChemicalBook | CB3458912 | |
| Guide to Pharmacology | 6797 | |
| rxnorm | AZOPT | BRINZOLAMIDE |
| PubChem: Drugs of the Future | 12015162 | |
| KEGG Ligand | C07760 | |
| ChEBI | 3176 | |
| ZINC | ZINC000003953037 |
